cagrilintide phase 2 New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 3a trial) Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE phase 3a trial) semaglutide cagrilintide Cagrilintide–semaglutide (CagriSema) versus
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18




01751-7/asset/6309d074-38cb-40bc-984b-962ca1dbd6df/main.assets/gr2b_lrg.jpg)

























